Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)
Titel:
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)
Auteur:
Welte, Tobias Dellinger, R. Phillip Ebelt, Henning Ferrer, Miguel Opal, Steven M. Singer, Mervyn Vincent, Jean-Louis Werdan, Karl Martin-Loeches, Ignacio Almirall, Jordi Artigas, Antonio Ignacio Ayestarán, Jose Nuding, Sebastian Ferrer, Ricard Sirgo Rodríguez, Gonzalo Shankar-Hari, Manu Álvarez-Lerma, Francisco Riessen, Reimer Sirvent, Josep-Maria Kluge, Stefan Zacharowski, Kai Bonastre Mora, Juan Lapp, Harald Wöbker, Gabriele Achtzehn, Ute Brealey, David Kempa, Axel Sánchez García, Miguel Brederlau, Jörg Kochanek, Matthias Reschreiter, Henrik Peer Wise, Matthew P. Belohradsky, Bernd H. Bobenhausen, Iris Dälken, Benjamin Dubovy, Patrick Langohr, Patrick Mayer, Monika Schüttrumpf, Jörg Wartenberg-Demand, Andrea Wippermann, Ulrike Wolf, Daniele Torres, Antoni